ENDOCYTE INC's ticker is and the CUSIP is 29269A952. A total of 3 filers reported holding ENDOCYTE INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,016,000 | -23.3% | 57,200 | -40.4% | 0.01% | -27.3% |
| Q2 2018 | $1,325,000 | -11.8% | 96,000 | -42.0% | 0.01% | -26.7% |
| Q1 2018 | $1,503,000 | +71.2% | 165,400 | -19.4% | 0.02% | +150.0% |
| Q4 2017 | $878,000 | +177.8% | 205,200 | -8.5% | 0.01% | +100.0% |
| Q3 2017 | $316,000 | +42.3% | 224,300 | +51.7% | 0.00% | +50.0% |
| Q2 2017 | $222,000 | +22100.0% | 147,900 | +49200.0% | 0.00% | – |
| Q4 2016 | $1,000 | -85.7% | 300 | -86.4% | 0.00% | – |
| Q3 2016 | $7,000 | -85.4% | 2,200 | -85.8% | 0.00% | -100.0% |
| Q1 2016 | $48,000 | -25.0% | 15,500 | -3.1% | 0.00% | 0.0% |
| Q4 2015 | $64,000 | +6.7% | 16,000 | +21.2% | 0.00% | 0.0% |
| Q3 2015 | $60,000 | -49.2% | 13,200 | -41.9% | 0.00% | -50.0% |
| Q2 2015 | $118,000 | -5.6% | 22,700 | +13.5% | 0.00% | 0.0% |
| Q1 2015 | $125,000 | -75.8% | 20,000 | -75.6% | 0.00% | -75.0% |
| Q4 2014 | $516,000 | -72.5% | 82,100 | -73.4% | 0.01% | -72.4% |
| Q3 2014 | $1,876,000 | -23.0% | 308,600 | -16.5% | 0.03% | -23.7% |
| Q2 2014 | $2,437,000 | -47.9% | 369,800 | +88.3% | 0.04% | -51.9% |
| Q1 2014 | $4,676,000 | +1291.7% | 196,400 | +525.5% | 0.08% | +1480.0% |
| Q4 2013 | $336,000 | -54.9% | 31,400 | -43.8% | 0.01% | -64.3% |
| Q3 2013 | $745,000 | +609.5% | 55,900 | +598.8% | 0.01% | +366.7% |
| Q2 2013 | $105,000 | – | 8,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 82,100 | $516,000 | 0.01% |
| SIMPLEX TRADING, LLC | 61 | $8,000 | 0.00% |
| Citadel Advisors | 54,600 | $343,000 | 0.00% |